Independent Non-Executive Director
MD B.A.
Skills and experience
Dr. Maria Rivas, MD is an experienced public company board director and S&P 100 senior pharmaceutical executive with 25+ years’ experience in late-stage clinical development, commercialization and governance leadership. Dr. Rivas holds a B.A. in Biochemistry from Brandeis University and an MD from Columbia University’s Vagelos College of Physicians and Surgeons. She completed residency training in Internal Medicine and a fellowship in Endocrinology at New York-Presbyterian Hospital.
Career Summary
Dr. Rivas spent over 25 years in healthcare developing and commercializing medical devices and pharmaceutical products across multiple therapeutic areas including oncology, rare diseases and neurosciences most recently as Chief Medical Officer at Pfizer, Inc. (NYSE: PFE). She has managed global operations of several thousand data scientists, healthcare experts and field staff, and overseen the launch of multiple blockbuster medical products. Dr. Rivas currently serves on the board of directors of The Cooper Companies, Inc. (NASDAQ: COO), and the advisory board of Proxy Foods. From 2018-2019, Dr. Rivas served as an independent director for Medidata Solutions, Inc. (NASDAQ: MDSO) until its successful merger with Dassault Systèmes.